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Abstract: 
Healthcare has only slowly appeared on the EU’s policy agenda. EU involvement in policies 
concerning the organization, financing, and the provision of diagnosis, care, and cures to ill 
people developed along three fragmented tracks: a. EU public health policies concerning the 
well-being of all people; b. the application of the free movement principle to national 
healthcare systems in particular by the EU’s Court of Justice (CJEU); and c. the austerity 
packages and the stricter EU surveillance of national budgets since the debt crises. The key 
questions of this special issue are whether this fragmented EU involvement has now 
developed into a distinct European healthcare union, and if so, what its driving forces have 
been. Thus, it explores how European integration in healthcare has moved forward despite 
widespread reluctance. It also examines the underexplored political dynamics and 
implementation of CJEU case law. The conclusion is that a fragile European healthcare union 
is emerging. A distinct area of EU health law has come into existence, whereas an 
institutional structure has given a voice to health expertise. A certain commonality in 
patients’ rights has also emerged. The EU’s budgetary surveillance deeply intrudes into 
healthcare policies, but here, the involvement of health actors has remained limited. The 
European Commission and the CJEU have played an important role in the European 
integration of healthcare policies, but reluctance towards EU intrusion into national 
healthcare systems left an emphatic mark on CJEU case law, its codification in EU law and its 
implementation. Variants of the multiple streams approach appeared to be helpful to 
explain this evolution. 
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 The economic and monetary union, the European banking union, the European the solidarity 
union, the European democratic union, the European innovation union, the European fiscal 
union, the European defence union, the European capital markets union, the European 
energy union, the European political union… the European Union (EU) has produced an 
abundance of unions, although some unions are more developed than others. Despite all of 
the legitimacy and debt crises, European integration still advances. However, does this 
advance also hold true for healthcare, even if many people prefer to almost exclusively 
maintain national control? The rise of a “new compound European healthcare state” has 
already been observed (Lamping 2005, 43). Thus, is a European healthcare union in the 
making, and if so, what are its driving forces? These are the key questions of this special 
issue. 
The concept of a European healthcare union consists of three components (cf. Vollaard, Van 
de Bovenkamp, and Martinsen 2015). The first component, European, refers to the EU. 
Healthcare involves the organization, financing, and the provision of diagnosis, care, and 
cures to ill people, including pharmaceuticals and medical devices. Healthcare should thus 
be distinguished from the closely related area of public health, which includes all policy 
measures to increase the physical and mental well-being of all people (such as anti-pollution 
policies). The final component, union, refers to a commonality that makes a collection of 
units (in casu healthcare systems) a distinct entity. First, this commonality may vary in 
nature. Concerning healthcare unions, commonality may involve the common use by 
professionals, patients or other actors of healthcare systems, the common values and 
standards that guide these healthcare systems, the union’s common institutions for 
healthcare policy-making, or a common regulation or financing of (parts of) the healthcare 
systems. Second, a union may also vary in strength. Commonality will be stronger if 
standards, values, guidelines, and legislation are more binding and the units are more 
mutually dependent and tied to one another. 
Healthcare is one of the least likely cases of European unification (Martinsen 2005, 1036). 
For a long time, there was no explicit reference to healthcare in the treaties of the EU and its 
predecessors. The EU was not expected to interfere in the healthcare systems of the 
member states (Martinsen and Falkner 2011). Since the Single European Act (in force since 
1987), these treaties have included the general principle to maintain a high level of health 
protection in the activities and policies of the EU, but only the Maastricht Treaty (in force 
since 1993) provided a legislative base for the EU’s supplementary role in the related area of 
public health. Only when national governments and parliaments felt that their healthcare 
prerogatives were threatened in the late 1990s, they amended the treaties to restrain EU 
involvement in healthcare. The present version of the Treaty of the Functioning of the 
European Union states (TFEU) in Article 168(7) that “[t]he Union should respect the 
responsibilities of the Member States for the definition of their health policy and for the 
organization and delivery of health services and medical care. The responsibilities of the 
Member States shall include the management of health services and medical care and the 
allocation of the resources assigned to them.” In addition to national governments and 
parliaments, a considerable majority of the population in the EU prefers national decision-
making on healthcare over EU involvement (European Commission, 2010). Furthermore, few 
EU citizens have sought planned healthcare in another EU member state (Rosenmöller et al., 
2006; European Commission, 2015). Perhaps for these reasons, there has been only limited 
support from civil society organizations in favour of EU legislation of healthcare issues, such 
as patient mobility (Greer and Rauscher 2011: 235). Moreover, the Directorate-General of 
the European Commission that is responsible for health issues, the DG SANTÉ, is not known 
to be very strong. Expanding the EU’s role in healthcare policies is thus rather unlikely given 
the narrow legal basis and the limited set of relatively weak advocates. 
However, healthcare has slowly appeared on the EU’s policy agenda since the 1990s (Hervey 
and Vanhercke, 2010). EU involvement in healthcare policies initially developed along two 
different tracks. a. EU public health policies concerning issues such as AIDS, cancer, smoking, 
blood safety, BSE, SARS, Ebola, and ageing were partly based on the policy networks of 
health professionals (Lamping and Steffen, 2009; Trubek et al, 2009); b. The second track is 
the application of the principle of free movement in the EU’s internal market to national 
healthcare systems in particular by the Court of Justice of the European Union (CJEU) at the 
request of the national courts (Brooks, 2012; Leibfried, 2010; Martinsen, 2005). The resulting 
EU role in healthcare constituted a “law and policy patchwork” (Hervey and Vanhercke, 
2010). In recent years, two major developments have marked the EU’s involvement in 
healthcare policies. Early on, the EU’s predecessors co-regulated the access to healthcare 
systems and the recognition of pharmaceuticals, diplomas of health professionals, and 
medical devices in the internal market. However, in response to a series of CJEU verdicts 
since 1998, the EU eventually adopted in 2011 a directive that should facilitate access to 
healthcare services in the EU, which reaches the heart of healthcare provision.2 Additionally, 
the EU expanded its role in healthcare policies along a third track, as part of the austerity 
packages and the stricter EU surveillance of national budgets since the debt crises (Greer, 
2014). The question is therefore whether and how the previous patchwork has now been 
replaced by a healthcare union with a distinct and common set of institutions, regulations, 
values, and practices. 
This up-to-date empirical overview of a European healthcare union in the making serves 
several purposes. First, this overview provides the necessary input for normative discussions 
on the desirability and justifiability of the nature and level of EU involvement in healthcare 
policies. Should healthcare be primarily considered a heavy budgetary burden, a prerequisite 
of economic growth, the centre of innovative research, or an expression of solidarity 
between the sick and the healthy and the rich and the poor? Moreover, should solidarity, 
budget, economic growth, and innovation be mostly a European or national (or regional) 
matter? If they are addressed at all, these fundamental choices in the organization of a 
European healthcare union are often a matter of fragmented, technocratic and depoliticized 
debates that are dominated by policy experts (Hervey and Vanhercke, 2010: 129-130). Even 
if policy experts can significantly disagree – for example, on the issue regarding whether the 
EU can define and enforce common standards concerning the quality of care (Vollaard, van 
de Bovenkamp, and Vrangbæk 2013) – policy discussions may still evolve in a direction that 
is different than if the discussion would have been politicized and the greater public would 
have been directly involved. This evolution may be even more accurate given the reluctance 
of the mass public towards a (larger) EU role in healthcare policies.  
Public reluctance towards EU involvement in healthcare also provides the theoretical 
relevance of an exploration of the European healthcare union in this special issue. How can 
European integration advance in a period in which the politicization of European integration 
and the adherence to national identity seems to override functional imperatives to address 
certain policy problems more effectively on a European scale (Hooghe and Marks, 2008)? In 
some instances, supranational actors such as the European Commission may still have been 
able to push for more European integration when it was shielded from too much public or 
electoral scrutiny (Schimmelfennig, 2014). This special issue devotes particular attention to 
the role of the courts in the continuation of European integration. Healthcare is a pre-
eminent case in this respect. The CJEU has been identified as an influential actor in EU 
healthcare policies. The CJEU has been even described as “Ersatz legislator” (Lamping, 2005). 
The CJEU decided path-breaking verdicts on issues such as the trade of pharmaceuticals and 
cross-border patient mobility. However, even if a considerable amount of scholarly literature 
has often mentioned the potential influence of the CJEU (Kelemen 2013; Stone Sweet 2010), 
its actual impact has remained underexplored. Whether and how the CJEU can be a driving 
force of integration thus still deserves more attention in EU studies. This special issue 
therefore focuses specifically on the CJEU’s role in European integration. This issue’s focus is 
from various angles because the CJEU heavily depends on other actors to have any impact at 
all. Its preliminary rulings to explain a piece of EU legislation occur at the request of the 
national courts. The CJEU also relies on the same national courts for the application of its 
case law in legal cases. Additionally, the CJEU depends on political actors such as the 
European Commission and the member states to act according to the “voice of law”, both 
practically and legally. An exploration of the role of the CJEU therefore requires a broader 
understanding of the relation between law and politics. 
The papers in this special issue are selected to provide the necessary empirical overview of 
EU involvement in healthcare policies and to improve in particular the understanding of the 
relation between law and politics in the European integration process. This issue will answer 
the two key questions that are presented above. The descriptive question regarding whether 
a European healthcare union is in the making is first addressed from a general point of view. 
Tamara Hervey discusses whether and how EU health law has emerged as a distinct area of 
law. Anniek de Ruijter presents the historical evolution of the EU institutions that are 
involved with human health. The following contributions examine the EU’s involvement in 
healthcare policies in one of the three different tracks. Scott Greer and Olga Löblová focus 
on the role of the EU in the public health-related issues of communicable diseases and 
Health Technology Assessment (HTA). Three contributions explore the emerging role of the 
EU in healthcare because of the application of internal market principles to national 
healthcare systems, in particular by the CJEU. The CJEU verdicts on cross-border patient 
mobility since 1998 constitute major instances of legal interference into national healthcare 
systems. Therefore, these contributions focus specifically on these verdicts, their 
implementation, and also the 2011/24/EU directive on the application of patients’ rights in 
cross-border healthcare, which attempted to codify CJEU case law. These contributions also 
seek to address the scarcity of studies concerning the implementation of healthcare-related 
EU law (Lamping, 2013). In their contribution, Dorte Sindbjerg Martinsen and Juan Mayoral 
Diaz-Asensio examine the extent to which national courts refer to CJEU case law in Spain and 
Denmark. Hans Vollaard analyses whether and how territoriality, a key aspect of the politico-
legal order of the Westphalian state, matters in the implementation of CJEU case law and 
the directive in the Netherlands and Belgium. Nikolay Vasev, Karsten Vrangbæk, and Filip 
Křepelka discuss the variegating implementation of the case law in the Central and Eastern 
European countries of Poland, Bulgaria, and the Czech Republic. The third track of EU 
involvement in healthcare policies is explored by Rita Baeten and Bart Vanhercke, who show 
the extent to which this track is part of the recommendations concerning national budgets 
and national economic policies in the framework of the European Semester.  
 
Is a European healthcare union in the making? 
The overall conclusion that can be derived from the contributions that are presented here is 
that, however fragile, a European healthcare union is emerging. EU involvement in 
healthcare policies is no longer a patchwork that is only known under other labels, such as 
the internal market. EU involvement in healthcare policies is no longer only justified by and 
based on its contribution to economic growth, budgetary stability, or improving the health 
conditions of the entire population. EU involvement in healthcare policies is currently also 
specifically labelled as healthcare and also motivated by making ill people better regardless 
of their income or status in the EU area. In her contribution, Hervey thus shows how the 
legal regulation of healthcare in the EU is no longer a matter of EU law that is applied to 
healthcare or healthcare law that is applied to the EU. Instead, a distinct area of EU health 
law has been narrated into existence over the years (Hervey, 2016). Additionally, De Ruijter 
maps the consolidation of health expertise in the European Union (De Ruijter 2016). The 
contribution examines the different EU institutions and how a distinct health expertise was 
gradually formed and became critical to how the field was defined and its scope was set. The 
Commission is at the centre of the process, although not as a unitary actor. De Ruijter details 
how healthcare historically was spread across different DGs and Commissioners. Because of 
the BSE crisis, the DG SANCO (Directorate General for Food and Health Safety – and the 
predecessor of the DG SANTÉ) came into being in 1997. With SANCO, healthcare was marked 
as an independent portfolio, but that did not end internal power struggles within the 
Commission. Compared with other DGs, SANCO has been characterized as politically weak 
(Greer 2009; De Ruijter 2016). Nevertheless, SANCO took over the drafting of the patients’ 
rights directive from the DG MARKT after the European Parliament voted to negotiate cross-
border healthcare as part of the service directive (De Ruijter 2015, 234-235; Martinsen 2015, 
148-149). This negotiation implied a shift in policy discourse and placed healthcare expertise 
on the table to draft and negotiate the directive. De Ruijter also notes how health expertise 
has evolved into Union agencies and committees and has become a distinct area to be 
addressed in the European Parliament’s committee system and by member states’ 
healthcare attachés in the relevant Council working groups. The institutional structure of the 
Union has thus given a certain voice to and consolidation of health expertise. 
The contribution of Greer and Löblová shows that communicable disease control and health 
technology assessments have become important parts of EU healthcare integration (Greer 
and Löblová 2016). Given its considerable size, multi-dimensional nature, and complexity, 
the healthcare sector always involves actors from other policy areas with other policy 
principles. Thus, health technology assessment has appeared on the Union agenda as the 
solution to various problems, such as cost-containment of the healthcare sector. In some 
instances, healthcare actors could take the lead, however. For instance, Greer and Löblová 
identify the SARS outbreak in 2003 as the tipping point from which the health Commissioner 
could set a Community agenda for common actions against communicable diseases.  
The regulation of pharmaceuticals and to some extent health professionals in the internal 
market have been rather exceptional instances of the European involvement of healthcare 
actors since the 1960s and 1970s. The regulation of cross-border healthcare has been a 
much larger impetus for healthcare actors and principles to emerge at the EU level but only 
since the late 1990s. To be fair, since 1958 onwards, European law included arrangements 
for cross-border labourers to receive healthcare outside their system of affiliation under 
certain conditions. However, these arrangements were part of the coordination of social 
security systems in the internal market, and they were mostly addressed by ministers of 
social affairs rather than health ministers. In its series of verdicts on cross-border healthcare 
since 1998, the CJEU allowed patients to receive reimbursement of most extramural cross-
border healthcare without prior authorization, if it was covered by the health insurance 
package at home. Under certain conditions, patients could even also receive reimbursement 
for expensive and intramural care that was obtained abroad according to CJEU case law. The 
CJEU verdicts constituted a major incentive for health ministers and their civil servants to 
start discussing EU involvement in healthcare policies, initially mostly informally but 
eventually, also formally (Hervey and Vanhercke, 2010). Health ministers did not want to 
leave EU involvement in healthcare to the judges and actors from other policy areas with 
different policy principles. In 2004, the DG MARKT of the European Commission attempted 
to codify the CJEU case law in a general directive concerning the free movement of services, 
and a wide range of actors in the European Parliament and member states insisted that 
healthcare services should be arranged in a separate piece of legislation because of their 
specific nature. The health ministers subsequently agreed in 2006 on a set of common values 
and principles and emphasized the non-economic tenets of their healthcare systems, such as 
quality, safety, evidence-based ethical care, patient involvement, redress, privacy, and 
confidentiality (Council conclusions 2006). Furthermore, relying on ‘soft’ charters, 
declarations, conventions and recommendations by the EU, the Council of Europe and the 
World Health Organisation, the member states agreed in 2007 in the Lisbon Treaty to 
enshrine patients’ rights by referring to the binding Charter of Fundamental Rights of the EU. 
Accordingly, this charter states that “everyone has the right of access to preventive health 
care and the right to benefit from medical treatment under the conditions established by 
national laws and practices”. A certain commonality in patients’ rights has thus emerged in 
the EU. 
The DG SANCO of the European Commission eventually proposed in 2008 the “directive on 
the application of patients’ rights in cross-border healthcare”.3 After years of protracted 
negotiations, the European Parliament and the Council of the European Union (in which 
each member state is represented by a minister) agreed on a substantially modified directive 
(Martinsen 2015, see also below). Even if the reduction of legal uncertainty for patients who 
seek cross-border healthcare has been a main motive to adopt this directive, several 
observers have foreseen further court cases because of remaining ambiguities (Greer, 2013). 
As a result, not only the directive but also additional CJEU case law may be instrumental to 
advance some type of commonality in patients’ rights concerning issues such as informed 
choice, reimbursement, and aftercare. These instruments are dependent on the extent to 
which member states implement EU (case) law. Therefore, three contributions in this special 
issue examine whether and how the member states have implemented CJEU case law and 
the directive concerning cross-border healthcare because we still have limited knowledge 
regarding the actual impact of the CJEU at the national level. 
Martinsen and Mayoral Diaz-Asensio examine the impact of this process of judicialization in 
Denmark and Spain (Martinsen and Mayoral Diaz-Asensio 2016). They investigate the ex-
post judicial, administrative and political responses to legal integration and examine in 
particular the extent to which national courts activate EU law in their national proceedings. 
The comparison of Denmark and Spain show that the two universalistic healthcare models 
have so far proved resistant to judicialization and that there is a wide discrepancy between 
legal integration and the de facto rights that it has produced at the national level. The 
patient empowerment that was expected because of CJEU jurisprudence is not confirmed by 
the two case studies (Martinsen and Mayoral Diaz-Asensio 2016). Vollaard examines the 
extent to which CJEU jurisprudence and the patients’ rights directive, as part of a larger 
process of the liberalization of cross-border healthcare in the EU’s internal market, led to the 
end of territoriality in the provision of healthcare (Vollaard 2016). Conceptually, the 
contribution offers a distinction between the legal principle of territoriality, a core feature of 
the state, and territoriality as a political strategy of controlling people and phenomena such 
as patient mobility. In empirical terms, Vollaard shows that EU law, including CJEU 
jurisprudence, has created a new domain for cross-border healthcare on a European scale. 
Moreover, although EU law has undermined the legal principle of territoriality, member 
states also reinstated territorial control on a European scale through the patients’ rights 
directive. Territorial control is also still an integral part of the member states’ organization of 
healthcare, as reflected by the way EU law on cross-border healthcare has been 
implemented even in the Netherlands and Belgium, which are founding members with 
considerable experience in cross-border healthcare. Finally, the contribution by Vasev, 
Vrangbæk and Křepelka examines the impact of CJEU jurisprudence on cross-border 
healthcare in Central and Eastern European member states (Vasev, Vrangbæk, and Křepelka 
2016). They compare judicialization in the new member states with the previous findings of 
Obermaier, who identified a certain compliance with the jurisprudence in the UK, Germany 
and France (Obermaier 2009). In contrast to Obermaier, Vasev, Vrangbæk and Křepelka find 
that judicialization has not been able to drive change to any notable extent in the new 
member states that were examined. The case law has either been ignored or has only led to 
limited compliance. Together, these three contributions substantiate the contained nature 
of compliance with jurisprudence, as established in the seminal work of Lisa Conant (Conant 
2002; Conant 2001). This compliance leaves the legal commonality of patients’ rights in 
cross-border healthcare rather fragile because it remains highly dependent on the actual 
application on the ground.  
Baeten and Vanhercke bring us to the new avenue of EU healthcare integration through the 
recently intensified EU’s budgetary and economic surveillance of the member states (Baeten 
and Vanhercke 2016). The institutional landscape has changed regarding EU surveillance. 
Decisions are made by the troika/institutions of the European Central Bank, the International 
Monetary Fund (IMF) and the Commission in this matter and are enacted primarily by the 
DG ECFIN, not by the DG SANTE. Even if Baeten and Vanhercke demonstrate the varying 
impact of this surveillance across the EU member states, it deeply intrudes into national 
healthcare policies. The impact is especially extensive for the countries that receive financial 
support from the EU and the IMF, which are the ‘memorandum’ countries of Romania, 
Greece, Ireland, Cyprus and Portugal. Tied by ‘memorandums of understanding’, these 
member states receive very detailed prescriptions on how to reform their healthcare 
sectors, including reduction of pharmaceutical spending, the number of hospitals, hospital 
beds and healthcare professionals. The year 2010 is identified as the point in time of the 
‘game-change’; the financial and economic crises created a window of opportunity for the 
economic actors to apply their solutions to the healthcare sector. We find that the DG ECFIN 
is on the centre stage and applies austerity measures to the healthcare sector. With this 
‘game-change’, health system reforms are currently the core of the European economic 
governance procedure, but many actors are missing in defining the scope and limits of this 
intervention, such as national healthcare authorities, the DG SANTE, the European 
Parliament, and the national parliaments, among others. The ‘grand recession’ thus marks a 
turn in the evolving healthcare Union and challenges its emerging content (De la Porte and 
Natali 2014; Martinsen and Vollaard 2014). Fiscal constraints impede positive healthcare 
integration while simultaneously impacting considerably the scope and conditions of 
national healthcare systems (Scharpf 2002). Additionally, in contrast to cross-border patient 
mobility and public health, EU involvement is primarily dominated by non-health actors, 
which leaves the European healthcare union rather fragile and fragmented. Nevertheless, 
the austerity face of EU involvement in healthcare may also be a first integrative step 
towards common financing for national healthcare systems (cf. Vollaard et al., 2015). At 
least for countries with fiscal stress, the EU has provided loans and financial guarantees to 
maintain the state apparatus and the healthcare system.  
 
The drivers of a European healthcare union in the making: the dynamics of law and politics 
The European healthcare union has emerged and evolved despite member states insisting 
that the organization of welfare should primarily remain a national responsibility (Leibfried 
2010; Ferrera 2005). This evolution presents the classic question of European integration. 
Which driving dynamics have been at play and explain the emerging features of a European 
healthcare union? Research on EU healthcare integration indicates different dynamics and 
institutions in explaining the emerging field. One line of research focuses on crises- or 
problem-driven dynamics where the outbreak of communicable diseases, such as AIDS or 
the BSE crisis, or shared public health problems, such as obesity, have pushed for European 
solutions. In this expansion of Union involvement, the European Commission is presented as 
a successful entrepreneur that seized the window of opportunity and expanded EU power 
and provisions (Lamping and Steffen 2009; Steffen 2012; Kurzer and Cooper 2011; Greer and 
Löblová 2016, this volume). Confirming the neo-functionalist focus on the stimulating role of 
non-state actors, the DG SANTE is presented here as a key institution that accepted political 
leadership and ensured EU involvement in public health. Similarly, the influence of other 
non-state actors, such as professional medical networks, have been noted (Trubek et al., 
2009). 
In recent decades, the politicized issue of identity has begun to overshadow problem-solving 
as a key motive in discussions on European integration (Hooghe and Marks, 2009). The 
greater public is also no longer indifferent to what (supranational) elites have decided. The 
era of permissive consensus has thus come to an end. Greer and Löblová couple neo-
functional spill-over dynamics with Kingdon’s multiple streams approach to identify the 
impact of politicization and dissensus. In the two processes of agenda-setting that they 
examine, Greer and Löblová cannot identify the constraining dissensus of politics as 
presented by Liesbeth Hooghe and Gary Marks (Hooghe and Marks 2009), but they note that 
political dissensus may still apply in the decision-making phase of integration. The neo-
functionalist explanations above primarily concern issues of public health; these issues 
involve less reluctance among governments and the greater public concerning integration. 
The financing and organizing of healthcare may be a different story, however. Kingdon’s 
multiple streams approach, or variations of it, can still be helpful to explain whether a 
European healthcare union may yet emerge in the organized chaos of the EU despite a 
Eurosceptic mood (see also Vollaard and Martinsen 2014; Baeten and Vanhercke 2016). 
As noted above, the CJEU has played an important role in the integration of cross-border 
healthcare. The CJEU has constituted a major motivation for the making of EU health law. 
Tamara Hervey argues that when we can explain how EU health law emerged as a field, we 
must examine how and by whom the law was narrated (Hervey 2016). Hervey notes that 
narration is the core to the evolving EU health regulation, which is a process through which 
principles, content and themes are discerned and articulated. For the emerging EU 
healthcare law, three main groups have been involved, namely, the legislature, the courts 
and the academy. The national courts and the CJEU have been key actors in deciding the 
content and scope of the narration, but they have been joined by the national and EU 
legislatures and to a lesser extent, the academy. Each set of actors have their own 
interpretation of what constitutes the meaning of law, and they do not always agree. 
Especially the legislatures have insisted on ‘objective public interest’ to be part of the 
narration to protect the organization and capacity of national health care systems. The 
emphasis on ‘objective public interest’ has increasingly been recognized by the CJEU. The 
narration of EU healthcare law is thus also a process through which both the scope and the 
limits of EU regulation are defined. The narration of EU healthcare law is not a linear line of 
progression towards more EU regulation. In addition, the application of the narration and its 
implementation and impact is not a given or automatic but depends on its clarity, i.e., which 
Hervey terms ‘structural coherence’. 
Legal integration is also the focus of another line of research, in particular the field of cross-
border healthcare (Greer 2006; Martinsen 2005). Here the litigants, courts, and particularly 
the CJEU come to the forefront and explain the expansion of EU competences. The CJEU 
applied internal market principles to the healthcare area, and for almost a decade, 
progressive legal interpretations were able to advance what politics could or would not. 
However, the political reluctance towards any EU intrusion into national healthcare systems 
left its mark on both CJEU case law and its implementation. The integration process of Union 
cross-border healthcare details the dynamics of law and politics as they unfolded over time. 
Concerning the law, CJEU case law intervened in a highly sensitive political field. The CJEU 
likely did not anticipate the strong reactions against its legal moves. As noted by Greer and 
Jarman, the Court probably did not know much concerning the substance of healthcare or 
did not give much consideration to the impact of and responses to entering a ‘complex, 
politically difficult and very expensive area’ (Greer and Jarman 2012, 267). Regarding politics, 
healthcare ministers first strongly opposed CJEU intervention in the policy field but were 
soon unable to agree on a political response to legal integration. The member states waited 
for the Commission to take the initiative, but the Commission responded with ‘deafening 
silence’ (Palm et al. 2000, 78). Apparently, the European executive was crippled with internal 
disagreements between its Commissioners and DGs, and the European Parliament warned 
the Commission of the political defeat that it would suffer if it did not establish the 
appropriate balance among the principles of the internal market through subsidiarity 
(Martinsen 2015, 147-148).  
Meanwhile, the European Court continued to develop its interpretations on cross-border 
healthcare. As the rulings developed, their scope was gradually clarified. On the one hand, 
the Court applied its reasoning to all healthcare systems. On the other hand, the CJEU also 
established that deviations from the free movement principles were justifiable under certain 
conditions, thus ‘fine-tuning’ its jurisprudence (De Ruijter 2015, 228; Obermaier 2009). In 
July 2008, the Commission could finally present its proposal on patients’ rights in cross-
border healthcare. It was clear from early on that a majority of politicians in the Council and 
the European Parliament wanted to maintain national control with a large scope of 
healthcare treatments through prior authorization. The adopted version of the Directive 
thus came to modify the impact of the Court’s jurisprudence because it allowed for the use 
of prior authorization for not only hospital care but also highly specialized and expensive 
outpatient care – as defined by the member states. The Commission was highly unsatisfied 
with this political development and found that the extensive use of prior authorization in 
fact departed from the case law of the Court (Martinsen 2015, 171-172).  
At the same time, the CJEU, however, has taken a more ‘tempered’ approach and apparently 
adapted its behaviour to the European legislator (Hatzopoulos and Hervey 2013). Even 
during the decision-making process between the Council and the European Parliament, the 
CJEU adapted its reasoning concerning an extended use of prior authorization (Baeten and 
Palm 2013, 394).4 The law and politics dynamics that were involved in constructing the 
emerging healthcare Union thus demonstrate that legal integration was highly important 
from the outset, but the CJEU did not do it alone. The course of legal integration was 
occasionally modified and proved responsive to political positions. The CJEU did not need to 
adapt its position because its previous rulings were based on primary law, which from a 
formal point of view, can only be overridden through a Treaty amendment. Therefore, the 
adaptive behaviour of the Court is even more noteworthy, as observed by Hervey and 
McHale: “[t]he CJEU is not, of course, obliged to follow the legislature where it interprets 
Treaty provisions such as Article 56 TFEU, but in practice it usually does so” (Hervey and 
McHale 2015, 91). This implies a more fine-grained relation between law and politics than a 
simple neo-functionalist reading would suggest. This relation is where European politics 
plays a decisive role and where the Court is not politically blind but even looks for ‘political 
guidance’ on how to apply more open Treaty provisions (Baeten and Palm 2013, 394). 
The relation between law and politics is not only dynamic at the law-making stage. As 
illustrated in the three contributions concerning the implementation of CJEU case law and 
the patients’ rights directive, the healthcare union also consists of tensions and 
contradictions between the rules that emerge at the ‘federal’ level and how they are 
responded to at the national level. Moreover, the dynamic between law and politics plays 
out rather differently across and within member states because national courts and national 
governments vary in their application of EU law.  
To conclude, the contributions of this volume demonstrate that the emerging healthcare 
Union is a co-operative system that combines self-rule and shared rule (Vollaard, Van de 
Bovenkamp, and Martinsen 2015). A large part of healthcare is still organized by the 
member states, and the impact of the shared rule depends on its national implementation. 
At the same time, the two levels are intertwined, with overlapping competences through 
continuous interaction and disputes, and they attempt to settle the division of labour and 
define the line between shared rule and self-rule. The contributions of this volume present a 
broader set of actors, institutions and dynamics in the making of a European healthcare 
union than what arises from the interactions among an entrepreneurial Commission, a 
dynamic Court and reluctant national politicians suggest. This volume notes that the 
dynamics differ depending on where we are in the policy-making process and which sub-
area of healthcare we investigate. Together, the different pieces substantiate that when 
examining the emergence, content and outreach of a policy field, the way is long and 
winding from policy idea through politics to output. 
Although fragile, a European healthcare union is in the making. Healthcare can be produced, 
consumed and provided across the internal borders of the EU. A distinct field of law and set 
of institutions co-regulate healthcare, whereas common values, rights, and principles have 
been agreed on. Certainly, national healthcare systems have not been fully integrated into a 
single European healthcare system. Additionally, other policy actors and principles still leave 
their mark on EU involvement in healthcare policies. Moreover, in practice, compliance with 
EU legislation and case law on patient mobility remains rather variegated across and within 
member states. However, the EU has become an extra, although thin, primary regulatory 
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